- Service Name
MAGLUMI® Chemiluminescence Immunoassay System
- Industry
Biomedical, Diagnostics, In-vitro Diagnostics, Clinical Laboratory Instruments
- Main Value Proposition
The MAGLUMI® system provides laboratories with a complete set of solutions for efficient and accurate diagnostics.
- Description
The MAGLUMI® Chemiluminescence Immunoassay (CLIA) System is a high-throughput, fully automated in-vitro diagnostics solution. It offers a comprehensive test menu covering up to 236 parameters for accurate disease diagnosis.
- Key Features
High-throughput automation; Comprehensive test menu with up to 236 parameters; Accurate quantitative and qualitative results; Global presence in 156 countries
- Use Cases
The MAGLUMI® system is most valuable in clinical laboratories requiring high-throughput testing for various diseases, including routine diagnostics and specialized testing.
- Competitive advantages
Fully automated system for increased efficiency; Broad test menu that covers a wide range of diseases; Established global presence with a strong production capacity
- Strengths
The service excels in providing high-quality, automated diagnostic solutions that enhance laboratory productivity and accuracy.
- Positioning
The service positions itself as a leader in the in-vitro diagnostics market, focusing on innovation and high-quality solutions.
- Audience
Target users include clinical laboratories, healthcare providers, and diagnostic centers that require reliable and efficient diagnostic solutions.
- CTA
Learn More
- Tags
Chemiluminescence
In-vitro Diagnostics
Laboratory Solutions
High-throughput Testing
- Tagline
Start New Innovation, Be Excellent
- Tone of Voice
Innovative, Professional, Trustworthy
- Differentiation
The system's unique selling point is its high throughput and automation capabilities, making it suitable for various laboratory environments.
- Brand Positioning
Snibe is recognized for its commitment to continuous innovation and excellence in biomedical engineering.
- Founded
1995-01-01